CAMBRIDGE, Mass. — Synthpop, Inc., a healthcare artificial intelligence company focused on eliminating administrative bottlenecks across the patient journey, has raised $15 million in a Series A funding round. The new investment brings the company’s total funding to $23 million and will support the expansion of its multi-agent AI platform that automates healthcare business operations.
The round was led by Ansa Capital, with participation from Defy.vc, Peterson Ventures, Storm Ventures, and strategic investor Bruce Broussard. Marco DeMeireles, Co-Founder and Managing Partner at Ansa Capital, has joined Synthpop’s Board of Directors.
Synthpop’s platform integrates document intelligence, payer-aware reasoning, and conversational voice agents into a unified system capable of automating up to 80% of administrative tasks across provider, payer, and patient interactions. The system connects directly with major electronic health record (EHR), billing, and e-prescribe platforms and is already in use across workflows including prior authorizations, referrals, eligibility checks, claims follow-ups, and patient access.
“Point solutions can’t fix operational bottlenecks,” said Elad Ferber, CEO of Synthpop. “Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software. This funding helps us expand our coverage and deepen integrations so providers can scale their operations and expand access to care.”
Over the past year, Synthpop’s platform has processed more than two million patient interactions and integrated with eight leading EHR systems. Customers across sectors such as diagnostics, fertility, and durable medical equipment have reported dramatic efficiency gains. Tasks that once took 40 minutes are now completed in under a minute at a fraction of the cost—while maintaining compliance and transparency.
“Healthcare organizations have long been constrained by highly manual workflows and human capital bottlenecks,” said Marco DeMeireles of Ansa Capital. “AI-native solutions like Synthpop are the only way for them to fulfill rising demand and increased patient expectations. The early value delivered to customers has been extremely compelling; I’m thrilled to join the Board and partner with Elad and the Synthpop team.”
The funding follows the addition of the airt team—led by Davor Runje and Hajdi Cenan—to Synthpop’s roster. The pair previously built FastStream and FastAgency and contributed to Microsoft’s open-source AutoGen framework for agentic AI. Their expertise is expected to further enhance Synthpop’s AI workflow automation capabilities.
“Synthpop stood out to us for its ability to automate complex, real-world healthcare workflows with speed, accuracy, and compliance,” said Medha Agarwal, General Partner at Defy.vc. “Their multi-agent platform delivers immediate, measurable value for providers, dramatically reducing time, cost, and friction across the patient journey. With strong customer adoption and a world-class technical team, we believe Synthpop is building critical infrastructure for a more efficient, human-centered healthcare system.”
The company plans to use the new funds to grow its team, deepen product capabilities, and expand into additional healthcare verticals as it continues to build out a scalable foundation for next-generation healthcare operations.
